CLINICAL DATA
Check Out Our Results
Our Data
Aphex™ Independent Lab Test Data
Killing germs is a serious business. At Aphex BioCleanse Systems, we back our products with independent lab testing. Our products are tested continually in order to assure the high-quality results our customers expect and deserve. At Aphex™, we develop complete protective systems for many industries and each of our products is put through a rigorous series of tests to maintain our high standards.
- Utilization of the Corrositex Test Method to Evaluate a Sample Provided by Aphex Biocleanse Systems, Inc
- An in-vitro Time-kill Evaluation of One Test Material When Challenged With Various Bacterial Species
- Preliminary Antimitotic Efficacy Study of the Provided “Prep-it” Solution Against Trichophyton Mentagrophytes
- An In-Vitro Time-Kill Evaluation of One Test Product When Challenged with Candida Auris and Candida Albicans
- Poultry Study: Effects of Bac-D on Hatchability, Conductance, Growth Rate and Feed Conversion on Turkey Poults
- Poultry Study: Effects of Bac-D on Total Aerobic Bacteria Naturally Found on Broiler Breeder Eggs
- IN-VITRO TIME-KILL EVALUATION WITH VARIOUS BACTERIAL SPECIES
- Human Coronavirus, strain 229E (ATCC #VR-740)
- MRSA: Testing DermAphex against the efficacy of commercially available alcohol based hand sanitizers.
- H1N1: Influenza A (H1N1) virus was used to determine antiviral efficacy of disinfection using DermAphex.
- Rhinovirus 39: Antiviral efficacy study on DermAphex hand sanitizer using a protocol comparable to ASTM E 1053-97.
- Clostridium Difficile: The disinfectant efficacy of DermAphex was tested against Clostridium difficile spores (ATCC 9689).
- NDM-1: DermAphex efficacy was tested against the NDM-1 carbapenem antibiotic resistant strain of Klebsiella pneumoniae.
- PRD-1: The disinfectant efficacy of DermAphex was tested against Bacteriophage PRD-1.
- E.coli: The disinfectant efficacy of DermAphex was tested against E.coli.
- Skin Test: DermAphex was tested its irritancy potential.
- Staphylococcus aureus ATCC-6538 SanAphex Test Results
Investor Information
Interested in investment opportunities? Get in touch with us and we’ll get back to you on how you can get involved.


Our Office
1162 Pittsford Victor Rd. Ste. 220
Pittsford, NY 14534
Contact us
Main Office
Phone: 1-585-798-7775
Fax: 1-888-772-8228
Investor Relations
Phone: 1-585-386-0990